WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
www.bms.com
.
Bristol-Myers Squibb RSS Channel
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category Bristol-Myers Squibb
Title
Published Date
U.S. Food and Drug Administration approves Opdivo® (nivolumab) + Yervoy® (ipilimumab) for patients with hepatocellular carcinoma (HCC) previously treated with sorafenib
11 March 2020
Voluntis and Bristol-Myers Squibb to co-develop digital therapeutics for oncology
04 March 2020
BioMotiv and Bristol-Myers Squibb announce the launch of Anteros Pharmaceuticals
04 February 2020
U.S. Food and Drug Administration accepts for Priority Review Bristol-Myers Squibb's application for Opdivo (nivolumab) plus Yervoy (ipilimumab) in first-line non-small cell lung cancer
17 January 2020
Bristol-Myers Squibb completes divestment of manufacturing facility in Anagni, Italy
07 January 2020
Bristol-Myers Squibb completes acquisition of Celgene, creating a leading biopharma company
21 November 2019
Bristol-Myers Squibb and Pfizer announce randomized, controlled trial to evaluate the effect of atrial fibrillation screening on health outcomes in older individuals
15 November 2019
Bristol-Myers Squibb awards "Golden Tickets" for LabCentral to Carmine Therapeutics, STIMIT
31 October 2019
The Bristol-Myers Squibb-Pfizer Alliance and Fitbit collaborate to address gaps in atrial fibrillation detection with the aim of accelerating diagnosis
18 October 2019
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement
18 July 2019
Bristol-Myers Squibb provides update on pending merger with Celgene
24 June 2019
Bristol-Myers Squibb announces post-closing leadership team
05 June 2019
Award-winning actor and producer Sterling K. Brown joins Bristol-Myers Squibb in effort to share stories of What It's Like to Live with Cancer Today
16 May 2019
Bristol-Myers Squibb reports first quarter financial results
25 April 2019
Bristol-Myers Squibb shareholders approve Celgene acquisition
12 April 2019
European Commission approves Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) for first-line treatment of patients with intermediate- and poor-risk advanced renal cell carcinoma
15 January 2019
Bristol-Myers Squibb to acquire Celgene to create a premier innovative biopharma company
03 January 2019
Bristol-Myers Squibb and Boston Medical Center announce research collaboration to investigate markers of immuno-oncology response and resistance
17 December 2018
Bristol-Myers Squibb awards "Golden Tickets" for LabCentral to ReviveMed, Strand Therapeutics
26 November 2018
Bristol-Myers Squibb and Compugen announce clinical collaboration to evaluate therapeutic regimen in advanced solid tumors
11 October 2018
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Business & Industry
Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
Bayer Consumer Health leaders propose new principles for science-led self-care
GSK signs agreement to support pandemic preparedness in Europe
Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager
Research & Development
Treating cancer by sticking cells in place
Vitamin K prevents cell death: a new function for a long-known molecule
Disparities in United States COVID-19 vaccine distribution
New needle-free nasal vaccine shows promise for COVID-19
Scientists develop new biomimetic formulation for treating glioblastoma
SARS-CoV-2 hijacks nanotubes between neurons to infect them
Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants
Conferences & Events
New approach to treatment of deadly kidney cancer
SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
SMi's 22nd Annual Pain Therapeutics Conference
SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
SMi's 3rd Annual AI in Drug Discovery Conference
Regulatory Affairs
FDA approves first systemic treatment for alopecia areata
FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
FDA limits use of Janssen COVID-19 vaccine to certain individuals
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
FDA approves first generic of Symbicort to treat asthma and COPD
You are here:
Home
Bristol-Myers Squibb